NCT06863740 - Using Cannabis to Treat Restless Legs Syndrome | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 25, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

May 31, 2026

Conditions

Restless Leg Syndrome (RLS)

Interventions

DRUG

Cannabis oil

5:1 CBD:THC oral formulation with a concentration of 25 mg/g CBD and 5 mg/g THC in a pharmaceutical grade medium chain triglyceride (MCT) oil.

DRUG

Cannabis placebo

Placebo oil

Trial Locations (2)

RECRUITING

Sunnybrook Health Sciences Centre, Toronto

RECRUITING

University Health Network, Toronto

All Listed Sponsors

collaborator

University Health Network, Toronto

OTHER

lead

Sunnybrook Health Sciences Centre

OTHER